Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

448 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma.
Caccese M, Desideri I, Villani V, Simonelli M, Buglione M, Chiesa S, Franceschi E, Gaviani P, Stasi I, Caserta C, Brugnara S, Lolli I, Bennicelli E, Bini P, Cuccu AS, Scoccianti S, Padovan M, Gori S, Bonetti A, Giordano P, Pellerino A, Gregucci F, Riva N, Cinieri S, Internò V, Santoni M, Pernice G, Dealis C, Stievano L, Paiar F, Magni G, De Salvo GL, Zagonel V, Lombardi G. Caccese M, et al. Among authors: zagonel v. ESMO Open. 2024 Apr;9(4):102943. doi: 10.1016/j.esmoop.2024.102943. Epub 2024 Mar 15. ESMO Open. 2024. PMID: 38492275 Free PMC article.
Urine 2-Hydroxyglutarate in Glioma.
Lombardi G, Della Puppa A, Zagonel V. Lombardi G, et al. Among authors: zagonel v. Oncologist. 2016 Aug;21(8):1026. doi: 10.1634/theoncologist.2016-0123. Oncologist. 2016. PMID: 27507897 Free PMC article.
Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy.
Pasqualetti F, Orlandi P, Simeon V, Cantarella M, Giuliani D, Di Desidero T, Gonnelli A, Delishaj D, Lombardi G, Sechi A, Sanson M, Zagonel V, Paiar F, Danesi R, Guarini S, Bocci G. Pasqualetti F, et al. Among authors: zagonel v. Mol Neurobiol. 2018 Feb;55(2):1396-1404. doi: 10.1007/s12035-017-0414-9. Epub 2017 Feb 1. Mol Neurobiol. 2018. PMID: 28150230 Free article.
Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study.
Brandes AA, Finocchiaro G, Zagonel V, Reni M, Fabi A, Caserta C, Tosoni A, Eoli M, Lombardi G, Clavarezza M, Paccapelo A, Bartolini S, Cirillo L, Agati R, Franceschi E. Brandes AA, et al. Among authors: zagonel v. Oncotarget. 2017 Feb 25;8(33):55575-55581. doi: 10.18632/oncotarget.15735. eCollection 2017 Aug 15. Oncotarget. 2017. PMID: 28903444 Free PMC article.
Quality of Life Perception, Cognitive Function, and Psychological Status in a Real-world Population of Glioblastoma Patients Treated With Radiotherapy and Temozolomide: A Single-center Prospective Study.
Lombardi G, Bergo E, Del Bianco P, Bellu L, Pambuku A, Caccese M, Trentin L, Zagonel V. Lombardi G, et al. Among authors: zagonel v. Am J Clin Oncol. 2018 Dec;41(12):1263-1271. doi: 10.1097/COC.0000000000000459. Am J Clin Oncol. 2018. PMID: 29750673 Clinical Trial.
Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology.
Pasqualetti F, Pace A, Gonnelli A, Villani V, Cantarella M, Delishaj D, Vivaldi C, Molinari A, Montrone S, Pellerino A, Franchino F, Baldaccini D, Lombardi G, Lolli I, Catania F, Bazzoli E, Morganti R, Fabi A, Zagonel V, Bocci G, Fabrini MG, Rudà R, Soffietti R, Paiar F. Pasqualetti F, et al. Among authors: zagonel v. Am J Clin Oncol. 2018 Dec;41(12):1272-1275. doi: 10.1097/COC.0000000000000464. Am J Clin Oncol. 2018. PMID: 29782366
Good tolerability of maintenance temozolomide in glioblastoma patients after severe hematological toxicity during concomitant radiotherapy and temozolomide treatment: report of two cases.
Lombardi G, Caccese M, Bellu L, Pambuku A, Bergo E, Berti F, Gardiman MP, Della Puppa A, Denaro L, Dal Pos S, Zagonel V. Lombardi G, et al. Among authors: zagonel v. Anticancer Drugs. 2018 Oct;29(9):924-928. doi: 10.1097/CAD.0000000000000678. Anticancer Drugs. 2018. PMID: 30080691
448 results